相关实验视频
Updated: Sep 16, 2025

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
358
使用药物治疗治疗肥胖症的进展和挑战 (综述)
Saqer S Alotaibi1, Essam H Eldrehmy2, Sarah M Albogami1
1Department of Biotechnology, College of Science, Taif University, Taif 21944, Kingdom of Saudi Arabia.
Experimental and therapeutic medicine
|July 9, 2025
概括
新的抗肥胖药物 (AOMs) 针对胃肠道-下丘脑轴显示出有希望的结果. 虽然GLP-1激动剂有副作用,但激活神经素2受体 (NK2Rs) 的新型药物可能会提供更少不良事件的食欲抑制.
科学领域:
- 药理学 药理学是指药理学的学科.
- 内分泌学 在内分泌学.
- 胃肠病学 胃肠病学
背景情况:
- 肥胖是一个全球性健康危机,与增加的发病率和死亡率有关.
- 抗肥胖药物 (AOM) 对于管理这种慢性疾病至关重要.
- 胃肠道 (GI) - 脑下垂体轴调节食欲和能量消耗.
研究的目的:
- 审查AOM的最新进展及其对健康的影响.
- 探索肥胖管理的新型治疗目标.
- 讨论GI-hypothalamic轴在AOM发展中的作用.
主要方法:
- 关于AOMs的当前文献的审查.
- 基于激素的AOMs的分析,包括GLP-1受体激动剂.
- 研究针对神经素2受体 (NK2Rs) 的新型候选药物.
主要成果:
- GLP-1受体激动剂得到了广泛的研究,但通常会引起副作用.
- 针对NK2Rs的新型AOM在没有先前副作用的小鼠中显示出食欲抑制.
- 需要进一步的研究来解决胃肠道,胆囊和胰腺的副作用.
结论:
- NK2R激活为肥胖症治疗提供了一个有前途的途径.
- 需要进行临床试验来评估NK2R激动剂,特别是在高风险人群中.
- 解决与AOM相关的副作用仍然是未来研究的关键领域.
相关概念视频
Diabetes: Management and Pharmacotherapy
408
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
408
Atherosclerosis III: Management
41
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
41
Drug Therapy
107
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
107
Obesity
623
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
623
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
Inflammatory Bowel Disease IV: Pharmacological Management
200
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
200

